FDA — authorised 24 January 1969
- Marketing authorisation holder: MYLAN INSTITUTIONAL
- Status: approved
FDA authorised Sulfamylon on 24 January 1969
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 24 January 1969.
MYLAN INSTITUTIONAL holds the US marketing authorisation.